We are live on ! Find out more
EEG

E.E. Geduld Portfolio holdings

AUM $178M
1-Year Est. Return 29.34%
This Fund
S&P 500
This Quarter Est. Return
+20.65%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$100M
AUM Growth
+$24.3M
Cap. Flow
+$6.54M
Cap. Flow %
6.51%
Top 10 Hldgs %
56.12%
Holding
218
New
50
Increased
37
Reduced
21
Closed
27

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.77M
2
ARIA
Ariad Pharmaceuticals Inc
ARIA
+$661K
3
AGIO icon
Agios Pharmaceuticals
AGIO
+$653K
4
MU icon
Micron Technology
MU
+$610K
5
MLNX
Mellanox Technologies, Ltd.
MLNX
+$487K

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.06M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$823K
3
HTWR
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
+$578K
4
BVA
CORDIA BANCORP INC COM
BVA
+$499K
5
OPK icon
Opko Health
OPK
+$349K

Sector Composition

Rank Sector Weight
1 Financials 43.64%
2 Miscellaneous 21.13%
3 Healthcare 14.92%
4 Technology 7.13%
5 Consumer Discretionary 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAOI icon
51
Applied Optoelectronics
AAOI
$9.62B
$333K 0.33%
15,000
-18,000
-55% -$279K
HLND
52
DELISTED
HILAND PARTNERS, LP COMMON UNITS
HLND
$321K 0.32%
70,655
-2,835
-4% -$12.9K
PACB icon
53
Pacific Biosciences
PACB
$482M
$314K 0.31%
35,000
+5,000
+17% +$41.8K
CPE
54
CALL
DELISTED
Callon Petroleum Company
CPE
$314K 0.31%
+2,000
New +$265K
MCRB icon
55
Seres Therapeutics
MCRB
$49.7M
$307K 0.31%
+1,250
New +$439K
CCXI
56
DELISTED
ChemoCentryx, Inc.
CCXI
$302K 0.3%
50,000
+25,000
+100% +$118K
FNSR
57
DELISTED
Finisar Corp
FNSR
$298K 0.3%
+10,000
New +$219K
ZAYO
58
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$297K 0.3%
10,000
– –
MNDT
59
CALL
DELISTED
Mandiant, Inc. Common Stock
MNDT
$295K 0.29%
20,000
-30,000
-60% -$461K
UFI icon
60
UNIFI
UFI
$140M
$294K 0.29%
10,000
– –
CALY
61
Callaway Golf Company
CALY
$2.76B
$290K 0.29%
25,000
+10,000
+67% +$112K
NVDQ
62
DELISTED
Novadaq Technologies Inc.
NVDQ
$289K 0.29%
25,000
+10,000
+67% +$109K
LVS icon
63
Las Vegas Sands
LVS
$28.7B
$288K 0.29%
5,000
– –
MCD icon
64
McDonald's
MCD
$184B
$277K 0.28%
2,400
– –
PARA
65
DELISTED
Paramount Global Class B
PARA
$274K 0.27%
+5,000
New +$265K
CSLT
66
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$270K 0.27%
65,000
+15,000
+30% +$61.3K
OPK icon
67
CALL
Opko Health
OPK
$1.12B
$265K 0.26%
+25,000
New +$249K
BAC.PRA
68
DELISTED
Bank of America Corporation Depositary Shares, each representing a 1/1,000 th interest in a share of
BAC.PRA
$263K 0.26%
10,000
-5,000
-33% -$132K
LCAHU
69
DELISTED
Landcadia Holdings, Inc. Unit
LCAHU
$256K 0.26%
25,000
– –
EVBG
70
DELISTED
Everbridge, Inc. Common Stock
EVBG
$253K 0.25%
+15,000
New +$247K
SOJB
71
DELISTED
The Southern Company Series 2016A 5.25% Junior Subordinated Notes due October 1, 2076
SOJB
– –
0
– –
NOVN
72
DELISTED
Novan, Inc. Common Stock
NOVN
$252K 0.25%
+1,250
New +$261K
FRE.PRZ
73
DELISTED
FREDDIE MAC FIXED FLG RT NON CUM PERP PREF
FRE.PRZ
$244K 0.24%
70,000
– –
FRGI
74
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$240K 0.24%
+10,000
New +$242K
SHOR
75
DELISTED
ShoreTel, Inc.
SHOR
$240K 0.24%
+30,000
New +$235K
1 2
3
4 5

Similar funds

BC
Bocage Capital San Francisco, California $185M AUM 61.49% 1-Year Est. Return
PFM
PacWest Financial Management Phoenix, Arizona $169M AUM 8.84% 1-Year Est. Return
SRP
Saddle Road Partners Omaha, Nebraska $197M AUM 13.19% 1-Year Est. Return
CF
CenterStar Fund Chicago, Illinois $159M AUM 13.43% 1-Year Est. Return
SA
Steadfast Advisors New York $204M AUM 28.42% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
SIG
Stanford Investment Group Mountain View, California $205M AUM 7.44% 1-Year Est. Return
VWM
Vector Wealth Management Minneapolis, Minnesota $142M AUM 10.42% 1-Year Est. Return

E.E. Geduld's Q3 2016 Portfolio in Review

As of Q3 2016, E.E. Geduld held 218 positions worth $100M, up 32% from $76M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

E.E. Geduld deployed $6.54M of net new capital in Q3 2016, opening 50 new positions and adding to 37 existing holdings. Its largest new stake was Agios Pharmaceuticals: 15,000 shares worth $792K.

By sector, the portfolio is most concentrated in Financials at 44% of assets, down from 49% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was Opko Health, an estimated $349K trimmed.

  • E.E. Geduld's largest Q3 2016 buy was Agios Pharmaceuticals: 15,000 shares worth $792K.
  • E.E. Geduld added most to Bristol-Myers Squibb in Q3 2016, an estimated $1.77M increase.
  • E.E. Geduld's biggest Q3 2016 reduction was Opko Health, cutting an estimated $349K.
  • E.E. Geduld fully exited Tesla in Q3 2016, selling an estimated $1.06M.
  • E.E. Geduld's ten largest holdings make up 56% of its $100M portfolio in Q3 2016.
  • E.E. Geduld opened 50 new positions and closed 27 in Q3 2016.
  • E.E. Geduld's portfolio value rose 32% quarter-over-quarter to $100M.

Based on E.E. Geduld's 13F filing for Q3 2016, filed 2 Nov 2016.